1 most recent filing and news item mentioning INBP. Updated every 60 seconds.
LeadershipAug 20, 2026Positive
Wholly-owned Manhattan Drug Co subsidiary named Michael Richtmyer as Head of Operations. Market relevance: Signals strategic focus on manufacturing scale and operational excellence.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.